Perjeta 420mg Concentrate For Solution For Infusion

Country: Kenya

Language: English

Source: Pharmacy and Poisons Board

Active ingredient:

Pertuzumab

Available from:

F. Hoffman-la Roche Ltd, Basel Grenzacherstrasse 124 CH-4070 Basel, Switzerland

ATC code:

L01XC13

INN (International Name):

Pertuzumab

Dosage:

One 14 ml vial of concentrate contains 420 mg of…

Pharmaceutical form:

Concentrate For Solution For Infusion

Administration route:

INTRAVENOUS

Manufactured by:

Roche Diagnostics GmbH Sandhofer Street 116, Mannheim, D-68305, Germany

Therapeutic area:

pertuzumab

Product summary:

Shelf life: 36 months; Description: Pertuzumab is Clear to slightly opalescent,

Authorization status:

Registered - Valid

Search alerts related to this product